Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Allergy and Infectious Diseases (NIAID)
Eligible subjects will be randomized to receive a single intramuscular injection of either a half-dose or a whole dose of a currently approved influenza virus vaccine in their arm. Prior to vaccination, subjects will have one tube of blood drawn. Subjects will be given a 3-day diary card to record any symptoms they may experience and asked to return for a second and final visit approximately 21 days following vaccination. A second blood draw will be done.
Age
18–49
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Volunteers may be eligible for this trial if they:
Are able to and have given informed consent.
Are able to understand and comply with all study procedures and to complete study diary.
Are aged 18 to 49 years.
Are female, and are not pregnant.
Are available for all study visits.
You may not be if
Volunteers will not be eligible for this trial if they:
Are allergic to eggs or egg products.
Have a current chronic medical condition for which influenza vaccine is normally recommended.
Have received experimental vaccines or medications within 30 days of study entry.
Have received parenteral immunoglobulin within 30 days of study entry.
Clareo Health | Half-Dose Flu Vaccine Study in Healthy Adults
